Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)
The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions.
By: Daedal Research
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global immuno-oncology market is dominated with few major market players operating worldwide. Further, key players of the immuno-oncology market with focus on assays are Merck and Co., Pfizer Inc., Amgen and F. Hoffmann-La Roche are also profiled with their financial information and respective business strategies.
Merck and Co.
F. Hoffmann-La Roche
Immuno-oncology, also called as cancer immunotherapy work with the help of the organs of the immune system detecting the cancer cells as foreign bodies and thereby helping to fight against cancer. Immunotherapies help to cure lung cancer, prostate cancer, breast cancer, colorectal cancer, melanoma, head and neck cancer and various other types. There are certain benefits and risks involved in treating the cancer with the help of immunotherapies, so care must be taken while using immunotherapy along with the conventional therapies in the treatment.
Immuno-Oncology assays are the next generation sequencing application which helps in maintaining the cell health and the cell forms by ensuring the continuous analysis. The cell based immuno-oncology assays can be segmented into T Cell Assays, Natural Killer Cell Assays, Tumor Killing Assays and Tumor Cell Assays.
The global immuno-oncology market has increased at a significant growth during the year 2018 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2019-2023 tremendously.
For further details, kindly visit :
(Business Development Manager)
Address: 36 SFS Flats
Mail ID - info@daedal-